Protein Structure and Function — MCQs
On this page
Which of the following amino acids is not coded by a standard triplet codon?
Which of the following is/are extracellular matrix protein?
Cathelicidins are rich in which of the following amino acids?
Where does protein synthesis occur?
Vitamin K dependent clotting factors include all EXCEPT?
In a seriously ill patient, the addition of amino acids to the diet results in a positive nitrogen balance. What is the mechanism for this effect?
In type I collagen, which terminals correspond to the telopeptide region?
Which of the following statements is FALSE regarding Cytochrome P 450?
What are amphipathic helices?
What is the amino acid at the reducing end of glutathione?
Protein Structure and Function Indian Medical PG Practice Questions and MCQs
Question 1: Which of the following amino acids is not coded by a standard triplet codon?
- A. Lysine
- B. Hydroxyproline (Correct Answer)
- C. Selenocysteine
- D. Pyrrolysine
Explanation: ### Explanation The correct answer is **B. Hydroxyproline**. **1. Why Hydroxyproline is the correct answer:** In protein synthesis, amino acids are typically incorporated into polypeptide chains via **translation**, guided by the genetic code. Hydroxyproline is a **non-standard amino acid** that is not coded by a specific triplet codon. Instead, it is formed through the **post-translational modification** of Proline residues already present in a protein chain (most notably collagen). This hydroxylation is catalyzed by the enzyme *prolyl hydroxylase*, which requires Vitamin C (ascorbic acid), ferrous iron, and oxygen as cofactors. **2. Analysis of Incorrect Options:** * **A. Lysine:** This is one of the 20 standard amino acids coded by the codons AAA and AAG. * **C. Selenocysteine:** Known as the **21st amino acid**, it is incorporated during translation via the **UGA** codon (normally a stop codon) when a specific "SECIS" element is present in the mRNA. * **D. Pyrrolysine:** Known as the **22nd amino acid**, it is coded by the **UAG** codon (amber stop codon) in certain methanogenic archaea and bacteria. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Scurvy Connection:** Deficiency of Vitamin C leads to defective hydroxylation of proline and lysine, resulting in unstable collagen triple helices. This manifests as bleeding gums, poor wound healing, and petechiae. * **21st vs. 22nd Amino Acid:** Selenocysteine is found in human enzymes like *Glutathione peroxidase* and *Thioredoxin reductase*. Pyrrolysine is NOT found in humans. * **Hydroxylysine:** Like hydroxyproline, it is also a post-translational modification and is not coded by a triplet codon.
Question 2: Which of the following is/are extracellular matrix protein?
- A. Collagen
- B. Laminin
- C. Fibronectin
- D. All of the above (Correct Answer)
Explanation: The **Extracellular Matrix (ECM)** is a complex network of macromolecules that provides structural and biochemical support to surrounding cells. It is primarily composed of fibrous proteins and glycosaminoglycans. **Explanation of Options:** * **Collagen (Option A):** This is the most abundant protein in the human body. It provides tensile strength to the ECM. Type I is found in bone and tendons, while Type IV is a key component of the basal lamina. * **Laminin (Option B):** A major glycoprotein of the **basal lamina**. It plays a crucial role in anchoring epithelial cells to the underlying connective tissue by binding to integrins and type IV collagen. * **Fibronectin (Option C):** An adhesive glycoprotein that helps cells attach to the ECM. It possesses specific binding domains for heparin, collagen, and **integrins** (via the RGD sequence), mediating cell adhesion and migration. Since all three proteins are integral components of the extracellular environment, **Option D (All of the above)** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** 1. **RGD Sequence:** Fibronectin contains the Arginine-Glycine-Aspartic acid (RGD) tripeptide, which is the primary recognition site for integrin receptors. 2. **Scurvy:** A deficiency in Vitamin C leads to defective collagen synthesis because it is a co-factor for the **prolyl and lysyl hydroxylase** enzymes. 3. **Alport Syndrome:** Caused by mutations in **Type IV Collagen**, leading to glomerulonephritis, sensorineural deafness, and ocular defects. 4. **Junctional Epidermolysis Bullosa:** Often associated with genetic defects in **Laminin** (specifically Laminin-332), resulting in severe skin blistering.
Question 3: Cathelicidins are rich in which of the following amino acids?
- A. Cysteine
- B. Cystine
- C. Methionine
- D. Arginine (Correct Answer)
Explanation: **Explanation:** **Cathelicidins** are a vital family of antimicrobial peptides (AMPs) that serve as a primary component of the innate immune system. They are characterized by a highly conserved N-terminal "cathelin" domain and a structurally diverse C-terminal domain that exhibits potent antimicrobial activity. **Why Arginine is the correct answer:** The antimicrobial efficacy of cathelicidins depends on their **cationic (positively charged)** nature. **Arginine** is a basic amino acid that carries a positive charge at physiological pH. This positive charge allows the peptide to electrostatically attract and bind to the negatively charged phospholipids (such as lipopolysaccharides) on the surface of bacterial membranes. Once bound, the peptide disrupts the membrane integrity, leading to cell lysis and death. In humans, the only cathelicidin-derived peptide is **LL-37**, which is notably rich in Arginine and Leucine. **Why other options are incorrect:** * **Cysteine/Cystine:** While some other antimicrobial peptides, like **Defensins**, are rich in Cysteine (forming disulfide bridges/Cystine), Cathelicidins are primarily defined by their cationic charge and amphipathic alpha-helical structures rather than disulfide stability. * **Methionine:** This is a sulfur-containing start codon amino acid but does not contribute to the cationic charge required for the specific function of cathelicidins. **Clinical Pearls & High-Yield Facts for NEET-PG:** * **LL-37:** The only human cathelicidin, produced by neutrophils and epithelial cells. * **Vitamin D Link:** The expression of the cathelicidin gene is regulated by Vitamin D; hence, Vitamin D deficiency is linked to increased susceptibility to infections like Tuberculosis. * **Disease Association:** Abnormal levels of LL-37 are seen in **Rosacea** (excessive) and **Atopic Dermatitis** (deficiency, leading to frequent skin infections). * **Comparison:** Remember: **Defensins = Cysteine-rich**; **Cathelicidins = Arginine-rich.**
Question 4: Where does protein synthesis occur?
- A. Ribosomes
- B. Mitochondria
- C. Golgi apparatus (Correct Answer)
- D. Endoplasmic reticulum
Explanation: **Explanation:** The question asks for the site of protein synthesis. However, based on the provided key marking **Golgi apparatus** as correct, it is important to clarify a common point of confusion in medical entrance exams regarding **post-translational modifications**. **1. Why Golgi Apparatus is the "Correct" Answer (Contextual):** While the *initiation* of translation occurs on ribosomes, the Golgi apparatus is the primary site for the final "synthesis" of functional, mature proteins. It is responsible for critical post-translational modifications such as **O-linked glycosylation**, sulfation, and phosphorylation (e.g., Mannose-6-Phosphate tagging). In many MCQ contexts, "synthesis" may refer to the completion of a functional protein product rather than just peptide bond formation. **2. Analysis of Other Options:** * **Ribosomes (Option A):** This is the actual site of **translation** (mRNA to polypeptide). In most standard biology contexts, this is the primary answer. * **Endoplasmic Reticulum (Option D):** The Rough ER is the site of synthesis for secretory, lysosomal, and membrane-bound proteins. It also handles **N-linked glycosylation**. * **Mitochondria (Option B):** These contain their own DNA and 70S ribosomes to synthesize a small fraction (approx. 13) of mitochondrial proteins. **3. NEET-PG High-Yield Pearls:** * **I-Cell Disease:** Caused by a failure of the Golgi to add **Mannose-6-Phosphate** to lysosomal enzymes, leading to their secretion outside the cell instead of being routed to lysosomes. * **Cis vs. Trans Golgi:** The *Cis*-face receives vesicles from the ER; the *Trans*-face (TGN) acts as the "sorting station" for final destination delivery. * **Brefeldin A:** A drug that inhibits protein transport from the ER to the Golgi.
Question 5: Vitamin K dependent clotting factors include all EXCEPT?
- A. Factor VII
- B. Factor VIII (Correct Answer)
- C. Prothrombin
- D. Factor IX
Explanation: **Explanation:** The correct answer is **Factor VIII** because it is not dependent on Vitamin K for its synthesis or function. Vitamin K acts as a vital cofactor for the enzyme **$\gamma$-glutamyl carboxylase**, which adds a carboxyl group to glutamate residues on specific clotting factors. This post-translational modification allows these factors to bind calcium ions ($Ca^{2+}$) and attach to phospholipid membranes, a crucial step in the coagulation cascade. **Breakdown of Options:** * **Factor VIII (Option B):** This is a glycoprotein synthesized primarily in the sinusoidal endothelial cells of the liver and extrahepatic sites. It functions as a cofactor for Factor IXa in the intrinsic pathway. It does not undergo $\gamma$-carboxylation and is therefore **not** Vitamin K dependent. * **Factor VII (Option A):** A Vitamin K-dependent serine protease that initiates the extrinsic pathway. It has the shortest half-life among all clotting factors. * **Prothrombin / Factor II (Option C):** A Vitamin K-dependent zymogen that is converted to thrombin. * **Factor IX (Option D):** A Vitamin K-dependent factor involved in the intrinsic pathway. **High-Yield NEET-PG Pearls:** 1. **Mnemonic:** Remember the Vitamin K-dependent factors as **"1972"** (Factors **10, 9, 7, and 2**) plus **Protein C and Protein S**. 2. **Warfarin Mechanism:** Warfarin inhibits **Vitamin K Epoxide Reductase (VKOR)**, preventing the recycling of Vitamin K and thus inhibiting the $\gamma$-carboxylation of these factors. 3. **Clinical Correlation:** In Vitamin K deficiency or Warfarin overdose, the **Prothrombin Time (PT)** is prolonged first due to the short half-life of Factor VII.
Question 6: In a seriously ill patient, the addition of amino acids to the diet results in a positive nitrogen balance. What is the mechanism for this effect?
- A. Increased absorption of amino acids from the intestine
- B. Enhanced rates of gluconeogenesis
- C. Increased secretion of insulin (Correct Answer)
- D. Increased Growth hormone secretion
Explanation: **Explanation:** **Mechanism of the Correct Answer (C):** The primary driver of a positive nitrogen balance following amino acid administration is the **anabolic action of insulin**. When amino acids (especially branched-chain amino acids like Leucine) enter the bloodstream, they act as potent secretagogues for the pancreatic beta cells. Insulin promotes a positive nitrogen balance by: 1. **Stimulating protein synthesis:** It increases the translation of mRNA into proteins. 2. **Inhibiting protein degradation:** It suppresses the ubiquitin-proteasome pathway. 3. **Increasing cellular uptake:** It facilitates the transport of amino acids into skeletal muscle. In a critically ill patient, this shift from a catabolic to an anabolic state is essential for recovery. **Analysis of Incorrect Options:** * **A. Increased absorption:** While absorption is necessary, it is a transport process, not the metabolic mechanism that dictates the *utilization* of nitrogen for tissue building. * **B. Enhanced gluconeogenesis:** This is a catabolic process where amino acids are broken down to produce glucose. This would lead to a **negative** nitrogen balance as the amino group is excreted as urea. * **D. Growth Hormone (GH):** While GH is anabolic, its secretion is primarily stimulated by hypoglycemia, fasting, or deep sleep. In the post-prandial or supplemented state, the acute metabolic response is dominated by insulin, not GH. **High-Yield Clinical Pearls for NEET-PG:** * **Nitrogen Balance Equation:** $B = I - (U + F + S)$ (Input minus losses in Urine, Feces, and Sweat). * **Positive Nitrogen Balance:** Seen in growth, pregnancy, and recovery from illness. * **Negative Nitrogen Balance:** Seen in starvation, severe burns, sepsis, and uncontrolled diabetes. * **Insulin vs. Glucagon:** Insulin is the "hormone of abundance" (anabolic), while glucagon/cortisol are "hormones of starvation/stress" (catabolic).
Question 7: In type I collagen, which terminals correspond to the telopeptide region?
- A. COOH-terminal
- B. NH2-terminal
- C. Both COOH and NH2-terminals
- D. Neither COOH nor NH2-terminals (Correct Answer)
Explanation: ### Explanation **1. Understanding the Correct Answer (Option D):** The synthesis of collagen involves the production of **Procollagen**, which contains large globular extensions at both the amino (NH2) and carboxyl (COOH) terminals. These extensions are called **propeptides**. Once procollagen is secreted into the extracellular space, specific enzymes called **procollagen peptidases** cleave these globular propeptides. The remaining molecule is called **Tropocollagen**. The **telopeptides** are the short, non-triple-helical sequences located at the extreme ends of the tropocollagen molecule *after* the propeptides have been removed. Therefore, telopeptides are distinct from the original NH2 and COOH terminals of the precursor procollagen chain. They serve as the primary sites for **lysyl oxidase-mediated cross-linking**, which provides tensile strength to the collagen fiber. **2. Why Other Options are Incorrect:** * **Options A & B:** These refer to the terminal ends of the procollagen molecule. The NH2 and COOH propeptides are discarded during maturation and do not constitute the telopeptide region of the functional collagen fiber. * **Option C:** While telopeptides exist at both ends of the triple helix, they are biologically and structurally defined as the "extra-helical" segments of tropocollagen, not the original terminals of the propeptide-containing precursor. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Cross-linking:** Telopeptides contain hydroxylysine/lysine residues that undergo oxidative deamination by **Lysyl Oxidase** (a Copper-dependent enzyme) to form covalent cross-links. * **Biomarkers:** Serum or urinary levels of **C-terminal telopeptide (CTX)** and **N-terminal telopeptide (NTX)** are used clinically as sensitive markers for **bone resorption** (increased in osteoporosis and Paget's disease). * **Scurvy:** Vitamin C is a cofactor for prolyl and lysyl hydroxylase; deficiency leads to unstable collagen because the triple helix cannot form properly without hydroxyproline.
Question 8: Which of the following statements is FALSE regarding Cytochrome P 450?
- A. They are essential for the production of cholesterols, steroids, prostacyclins, and thromboxane A2.
- B. They absorb light with 450 nm wavelength.
- C. They occur predominantly in the liver.
- D. They are non-heme proteins. (Correct Answer)
Explanation: ### Explanation **1. Why Option D is the Correct (False) Statement:** Cytochrome P450 (CYP) enzymes are **heme proteins** (specifically, hemeproteins of the b-type). They contain a heme group (iron-protoporphyrin IX) at their active site, which is essential for binding oxygen and the substrate. The iron atom in the heme undergoes redox reactions (cycling between $Fe^{2+}$ and $Fe^{3+}$) to catalyze the monooxygenation of various compounds. Therefore, calling them "non-heme proteins" is biochemically incorrect. **2. Analysis of Incorrect Options (True Statements):** * **Option A:** CYPs are vital for **endogenous synthesis**. They catalyze critical steps in the biosynthetic pathways of cholesterol, steroid hormones (in adrenal/gonads), and the conversion of arachidonic acid into prostacyclins and thromboxane A2. * **Option B:** The name "P450" is derived from the fact that when the heme iron is in the reduced state ($Fe^{2+}$) and bound to carbon monoxide (CO), the enzyme shows a characteristic **absorption peak at 450 nm**. * **Option C:** While present in almost all tissues (including kidneys, lungs, and intestines), they occur **predominantly in the liver** (specifically in the smooth endoplasmic reticulum), where they serve as the primary system for xenobiotic detoxification. **3. High-Yield Clinical Pearls for NEET-PG:** * **Reaction Type:** They are **Monooxygenases** (Mixed-function oxidases). They incorporate one atom of oxygen into the substrate and reduce the other into water. * **Electron Donor:** They require **NADPH** and the enzyme **NADPH-cytochrome P450 reductase**. * **Inducers vs. Inhibitors:** * *Inducers:* Phenytoin, Rifampicin, Griseofulvin (increase metabolism of co-administered drugs). * *Inhibitors:* Ketoconazole, Erythromycin, Cimetidine, Grapefruit juice (decrease metabolism, leading to toxicity). * **CYP3A4:** The most abundant isoform in the human liver, responsible for metabolizing ~50% of clinical drugs.
Question 9: What are amphipathic helices?
- A. Alpha helices with predominantly hydrophobic R-groups projecting from one side and predominantly hydrophilic R-groups projecting from the other side of the helix axis. (Correct Answer)
- B. Clusters of twisted strands of beta sheet.
- C. Short segments of amino acids that join two units of secondary structure.
- D. Supersecondary structures.
Explanation: **Explanation:** **Why Option A is Correct:** An **amphipathic (or amphiphilic) helix** is a specialized alpha-helix where amino acid residues are arranged such that **hydrophobic (non-polar)** R-groups concentrate on one face of the helix, while **hydrophilic (polar/charged)** R-groups concentrate on the opposite face. This spatial arrangement is achieved because the alpha-helix has 3.6 residues per turn; if polar and non-polar residues alternate every 3–4 positions, they align on separate sides of the cylindrical axis. This duality allows the helix to interface simultaneously with lipid environments (membranes) and aqueous environments (cytosol). **Why Other Options are Incorrect:** * **Option B:** This describes **Beta-barrels** or complex tertiary folds, not the specific property of an amphipathic helix. * **Option C:** This defines **Loops or Bends (Turns)**, which are non-repetitive secondary structures that connect alpha-helices and beta-sheets. * **Option D:** **Supersecondary structures** (or motifs) like the "Helix-turn-helix" or "Zinc finger" refer to specific combinations of secondary structures, whereas amphipathic helices are a specific *type* of secondary structure. **High-Yield Clinical Pearls for NEET-PG:** * **Apolipoproteins:** Amphipathic helices are hallmark features of proteins like **Apo A-I**, allowing them to bind to the hydrophobic lipid core of lipoproteins while remaining soluble in plasma. * **Membrane Proteins:** Many transmembrane channels use amphipathic helices to form a pore; the hydrophobic side faces the fatty acid tails of the bilayer, while the hydrophilic side forms the water-filled channel. * **Peptide Hormones:** Glucagon and certain antimicrobial peptides often adopt amphipathic helical structures to interact with target cell membranes.
Question 10: What is the amino acid at the reducing end of glutathione?
- A. Glycine
- B. Cysteine (Correct Answer)
- C. Lysine
- D. Glutamate
Explanation: ### Explanation **1. Why Cysteine is Correct:** Glutathione (GSH) is a tripeptide with the sequence **$\gamma$-L-Glutamyl-L-cysteinyl-glycine**. The term "reducing end" in the context of glutathione refers to the functional group responsible for its antioxidant properties. The **sulfhydryl (-SH) group** of the **Cysteine** residue is the active site that provides reducing equivalents. It neutralizes reactive oxygen species (ROS) and free radicals by donating a hydrogen atom. During this process, two glutathione molecules are oxidized to form a disulfide-linked dimer (GSSG). Therefore, Cysteine is the functional "reducing" component of the molecule. **2. Why Other Options are Incorrect:** * **Glutamate (D):** This is the N-terminal amino acid. It is unique because it is linked to Cysteine via a **$\gamma$-peptide bond** (using the side-chain carboxyl group) rather than a standard $\alpha$-peptide bond, making it resistant to intracellular peptidases. * **Glycine (A):** This is the C-terminal amino acid. While essential for the structural integrity of the tripeptide, it does not participate in redox reactions. * **Lysine (C):** Lysine is not a constituent amino acid of glutathione. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Glutathione Reductase:** Uses **NADPH** (primarily from the HMP Shunt) to reduce GSSG back to GSH. * **Glutathione Peroxidase:** A **Selenium-containing enzyme** that uses GSH to detoxify Hydrogen Peroxide ($H_2O_2$) into water. * **Clinical Correlation:** In **G6PD deficiency**, a lack of NADPH leads to depleted reduced glutathione, resulting in oxidative stress and hemolysis (Heinz bodies). * **Acetaminophen Toxicity:** N-acetylcysteine (NAC) is the antidote because it acts as a precursor to replenish hepatic glutathione stores.
Practice by Chapter
Amino Acids: Structure and Properties
Practice Questions
Peptide Bond Formation
Practice Questions
Primary Structure of Proteins
Practice Questions
Secondary Structure of Proteins
Practice Questions
Tertiary and Quaternary Structures
Practice Questions
Protein Folding and Chaperones
Practice Questions
Protein Domains and Motifs
Practice Questions
Structure-Function Relationships
Practice Questions
Hemoglobin and Myoglobin
Practice Questions
Collagen and Elastin
Practice Questions
Albumin and Plasma Proteins
Practice Questions
Post-Translational Modifications
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free